Literature DB >> 16176068

Purification of an endogenous inhibitor of L-Dopa decarboxylase activity from human serum.

Alice-Georgia Vassiliou1, Dido Vassilacopoulou, Emmanuel G Fragoulis.   

Abstract

An endogenous inhibitor of L-Dopa decarboxylase was identified and purified from human serum. In Triton X-114 partitioning experiments, the inhibitor was recovered in the detergent enriched phase, suggesting a hydrophobic nature. Purification was achieved by means of proteinase K digestion, ammonium sulphate precipitation, phenyl sepharose hydrophobic chromatography and subsequent extraction from a nondenaturing polyacrylamide gel. This purification scheme resulted in the isolation of a single 25 kDa band, bearing L-Dopa decarboxylase inhibitory activity. The purified molecule was found to be resistant to heat and digestion by various proteases. Proteolytic digestion of the purified inhibitor by pronase and aminopeptidase M was achieved only following carboxymethylation. The biological importance of the presence of an L-Dopa decarboxylase activity inhibitor in normal biological fluids remains to be elucidated. The better understanding of the regulation of Ddc enzymatic activity could prove valuable in the clarification of the enzyme's role in a series of pathological conditions, as well as, in physiological regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176068     DOI: 10.1007/s11064-005-2752-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  43 in total

1.  A 33.5-kDa heat- and protease-resistant NADH oxidase inhibited by capsaicin from sera of cancer patients.

Authors:  P J Chueh; D J Morré; F E Wilkinson; J Gibson; D M Morré
Journal:  Arch Biochem Biophys       Date:  1997-06-01       Impact factor: 4.013

2.  Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.

Authors:  S B Baylin; W R Weisburger; J C Eggleston; G Mendelsohn; M A Beaven; M D Abeloff; D S Ettinger
Journal:  N Engl J Med       Date:  1978-07-20       Impact factor: 91.245

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  An aminopeptidase occurring in pig kidney. I. An improved method of preparation. Physical and enzymic properties.

Authors:  E D Wachsmuth; I Fritze; G Pfleiderer
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

5.  Does phenylethylamine have a role in schizophrenia?: LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels.

Authors:  P R Buckland; R Marshall; P Watkins; P McGuffin
Journal:  Brain Res Mol Brain Res       Date:  1997-10-03

6.  Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

Authors:  M Y Zhu; A V Juorio; I A Paterson; A A Boulton
Journal:  Eur J Pharmacol       Date:  1993-07-20       Impact factor: 4.432

7.  Alternative splicing of the neurofibromatosis 1 gene correlates with growth patterns and neuroendocrine properties of human small-cell lung-carcinoma cells.

Authors:  T Koh; J Yokota; K Ookawa; T Kina; K Koshimura; S Miwa; T Ariyasu; H Yamada; M Osaka; H Haga
Journal:  Int J Cancer       Date:  1995-03-16       Impact factor: 7.396

8.  Presence of endogenous inhibitor of aromatic L-amino acid decarboxylase in monkey serum.

Authors:  M K Rahman; A Togari; K Kojima; K Takahashi; T Nagatsu
Journal:  Mol Cell Biochem       Date:  1984-08       Impact factor: 3.396

9.  Alkylation of cysteine with acrylamide for protein sequence analysis.

Authors:  D C Brune
Journal:  Anal Biochem       Date:  1992-12       Impact factor: 3.365

10.  Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis.

Authors:  A Gjedde; G C Léger; P Cumming; Y Yasuhara; A C Evans; M Guttman; H Kuwabara
Journal:  J Neurochem       Date:  1993-10       Impact factor: 5.372

View more
  6 in total

1.  L-Dopa decarboxylase expression profile in human cancer cells.

Authors:  Ioanna Chalatsa; Eleftheria Nikolouzou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Mol Biol Rep       Date:  2010-06-11       Impact factor: 2.316

2.  Release of membrane-associated L-dopa decarboxylase from human cells.

Authors:  Ioanna Chalatsa; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2011-04-11       Impact factor: 3.996

3.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

4.  Detection, purification and identification of an endogenous inhibitor of L-Dopa decarboxylase activity from human placenta.

Authors:  Alice-Georgia Vassiliou; Emmanuel G Fragoulis; Dido Vassilacopoulou
Journal:  Neurochem Res       Date:  2008-11-13       Impact factor: 3.996

5.  L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.

Authors:  Panagiota-Aikaterini Geomela; Christos K Kontos; Ioannis Yiotakis; Emmanuel G Fragoulis; Andreas Scorilas
Journal:  BMC Cancer       Date:  2012-10-20       Impact factor: 4.430

6.  Mecp2-null mice provide new neuronal targets for Rett syndrome.

Authors:  Rocio G Urdinguio; Lidia Lopez-Serra; Pilar Lopez-Nieva; Miguel Alaminos; Ramon Diaz-Uriarte; Agustin F Fernandez; Manel Esteller
Journal:  PLoS One       Date:  2008-11-07       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.